Spectrum Pharma (SPPI) Tops Q2 EPS by 24c

August 9, 2016 4:53 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Spectrum Pharma (NASDAQ: SPPI) reported Q2 EPS of ($0.05), $0.24 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $30.9 million versus the consensus estimate of $30.88 million.

Non-GAAP net loss was $0.5 million, or $(0.01) per basic and diluted share in the comparable period in 2015.

For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment